Usefulness and future prospects of confocal laser endomicroscopy for gastric premalignant and malignant lesions

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level. CLE has the fundamental potential to provide a histologic diagnosis, and may theoretically replace or reduce the need for performing biopsy for histology. The clinical benefits of CLE are more obvious in esophageal disease, including Barrett’s esophagus. Currently, this technology has been adapted to the diagnosis and surveillance of Barrett’s esophagus and related neoplasia. Standard white light endoscopy is the primary tool for gastric cancer screening. Currently, the only method available to precisely diagnose these lesions is upper endoscopy with an appropriate biopsy. A recent study showed that CLE could characterize dysplasia or cancer and identify the risk factors for gastric cancer, such as intestinal metaplasia and the presence of Helicobacter pylori in vivo, although fewer studies on CLE were performed on the stomach than on Barrett’s esophagus and other esophageal diseases. However, the application of CLE to routine clinical endoscopy continues to be refined. This review focused on the usefulness and future prospects of CLE for gastric premalignant and malignant lesions.

Original languageEnglish
Pages (from-to)511-515
Number of pages5
JournalClinical Endoscopy
Volume48
Issue number6
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Stomach
Lasers
Barrett Esophagus
Esophageal Diseases
Endoscopy
Stomach Neoplasms
Technology
Biopsy
Metaplasia
Early Detection of Cancer
Helicobacter pylori
Neoplasms
Histology
Light

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

@article{3b9f2a4c015f4bbe95546580e053bf0c,
title = "Usefulness and future prospects of confocal laser endomicroscopy for gastric premalignant and malignant lesions",
abstract = "Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level. CLE has the fundamental potential to provide a histologic diagnosis, and may theoretically replace or reduce the need for performing biopsy for histology. The clinical benefits of CLE are more obvious in esophageal disease, including Barrett’s esophagus. Currently, this technology has been adapted to the diagnosis and surveillance of Barrett’s esophagus and related neoplasia. Standard white light endoscopy is the primary tool for gastric cancer screening. Currently, the only method available to precisely diagnose these lesions is upper endoscopy with an appropriate biopsy. A recent study showed that CLE could characterize dysplasia or cancer and identify the risk factors for gastric cancer, such as intestinal metaplasia and the presence of Helicobacter pylori in vivo, although fewer studies on CLE were performed on the stomach than on Barrett’s esophagus and other esophageal diseases. However, the application of CLE to routine clinical endoscopy continues to be refined. This review focused on the usefulness and future prospects of CLE for gastric premalignant and malignant lesions.",
author = "SangKil Lee",
year = "2015",
month = "1",
day = "1",
doi = "10.5946/ce.2015.48.6.511",
language = "English",
volume = "48",
pages = "511--515",
journal = "Clinical Endoscopy",
issn = "2234-2400",
publisher = "Korean Society of Gastrointestinal Endoscopy",
number = "6",

}

Usefulness and future prospects of confocal laser endomicroscopy for gastric premalignant and malignant lesions. / Lee, SangKil.

In: Clinical Endoscopy, Vol. 48, No. 6, 01.01.2015, p. 511-515.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Usefulness and future prospects of confocal laser endomicroscopy for gastric premalignant and malignant lesions

AU - Lee, SangKil

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level. CLE has the fundamental potential to provide a histologic diagnosis, and may theoretically replace or reduce the need for performing biopsy for histology. The clinical benefits of CLE are more obvious in esophageal disease, including Barrett’s esophagus. Currently, this technology has been adapted to the diagnosis and surveillance of Barrett’s esophagus and related neoplasia. Standard white light endoscopy is the primary tool for gastric cancer screening. Currently, the only method available to precisely diagnose these lesions is upper endoscopy with an appropriate biopsy. A recent study showed that CLE could characterize dysplasia or cancer and identify the risk factors for gastric cancer, such as intestinal metaplasia and the presence of Helicobacter pylori in vivo, although fewer studies on CLE were performed on the stomach than on Barrett’s esophagus and other esophageal diseases. However, the application of CLE to routine clinical endoscopy continues to be refined. This review focused on the usefulness and future prospects of CLE for gastric premalignant and malignant lesions.

AB - Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level. CLE has the fundamental potential to provide a histologic diagnosis, and may theoretically replace or reduce the need for performing biopsy for histology. The clinical benefits of CLE are more obvious in esophageal disease, including Barrett’s esophagus. Currently, this technology has been adapted to the diagnosis and surveillance of Barrett’s esophagus and related neoplasia. Standard white light endoscopy is the primary tool for gastric cancer screening. Currently, the only method available to precisely diagnose these lesions is upper endoscopy with an appropriate biopsy. A recent study showed that CLE could characterize dysplasia or cancer and identify the risk factors for gastric cancer, such as intestinal metaplasia and the presence of Helicobacter pylori in vivo, although fewer studies on CLE were performed on the stomach than on Barrett’s esophagus and other esophageal diseases. However, the application of CLE to routine clinical endoscopy continues to be refined. This review focused on the usefulness and future prospects of CLE for gastric premalignant and malignant lesions.

UR - http://www.scopus.com/inward/record.url?scp=84948654025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948654025&partnerID=8YFLogxK

U2 - 10.5946/ce.2015.48.6.511

DO - 10.5946/ce.2015.48.6.511

M3 - Review article

VL - 48

SP - 511

EP - 515

JO - Clinical Endoscopy

JF - Clinical Endoscopy

SN - 2234-2400

IS - 6

ER -